Updated on
Summary BioNTech sues Moderna for patent infringement over COVID-19 shots
(Reuters) - Biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna's COVID-19 vaccine mNexspike infringes a patent related to BioNTech and Pfizer's competing shot Comirnaty.
Featured
